VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
NEOG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
NEOGNeogen Corporation
$13.57$3.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNEOGBalance Sheet

Neogen Corporation (NEOG) Balance Sheet

30Y historyFree accessUpdated daily

Total assets have shrunk 28% from $4.6B in 2024Q3 to $3.3B in 2026Q4, with goodwill falling from $2.1B to $1.0B and retained earnings swinging from $561M positive to -$544M, while the D/E ratio rose to 0.38 from 0.28 a year earlier.

Income StatementBalance SheetCash FlowRatios

NEOG Balance Sheet

Annual statement

NEOG Balance Sheet

Neogen Corporation (NEOG) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricMay'26May'25May'24May'23May'22May'21May'20May'19May'18May'17May'16May'15May'14May'13May'12May'11May'10May'09May'08May'07May'06May'05May'04May'03May'02May'01May'00May'99May'98May'97
Total Current Assets604.6M576.94M589.23M585.93M626.8M591.45M537.41M449.53M375.79M292.96M250M231.19M188.75M168.45M143.94M122.5M86.02M71.77M65.63M51.1M36.27M28.38M26.27M27.97M23.25M21.58M21.6M19.3M18.6M19M
Cash & Short-Term Investments185.5M129M170.94M245.57M381.05M381.09M343.67M267.52M210.81M143.63M107.8M114.16M76.5M85.37M68.64M56.08M22.81M13.84M14.27M13.42M1.96M1.97M1.7M8.9M6.35M7.18M10.67M10.7M700K700K
Cash Only185.5M129M170.61M163.24M44.47M75.6M66.27M41.69M83.07M77.57M55.26M66.06M40.67M50.03M49.05M35.84M22.81M13.84M14.27M13.42M1.81M1.97M1.36M1.06M2.01M848K2.2M1.1M700K700K
Short-Term Investments00325K82.33M336.58M305.49M277.4M225.84M127.74M66.07M52.54M48.1M35.82M35.34M19.6M20.24M0000150K0331K7.84M4.34M6.33M8.47M9.6M00
Accounts Receivable146.8M153.38M173M153.25M99.67M91.82M84.68M82.58M79.09M68.58M67.65M59.21M51.9M38.74M35.65M28.63M27.43M23.36M19.38M14.91M13.12M10.47M9.92M7.5M6.46M6.03M4.88M3.3M3.1M2M
Days Sales Outstanding61.5662.5868.3268.0169.0171.5473.9172.7872.5469.8676.8676.3476.5768.1370.760.5271.2671.8369.0863.266.0960.8965.2758.8857.3963.0375.7154.2661.1647.71
Inventory144.3M190.86M189.27M133.81M122.31M100.7M95.05M85.99M76M73.14M64.37M51.6M51.18M38.31M34.99M31.99M31.32M31.36M27.8M19.12M17.63M13.8M12.37M9.84M8.68M6.97M5.39M4.4M4.5M3.6M
Days Inventory Outstanding114.03147.19149.66117.27157.12145.05156.36141.21131.07140.99139.68131.35149.67142.65139.4137.56169.25193.08206.3167.83181.6156.61161.37165.03156.93148.37198.55186.74228.13234.64
Other Current Assets128M103.69M56.02M53.3M00000001.99M1.71M1.46M1.33M1.04M774K200K1.23M787K1.26M768K651K694K00662K900K10.3M12.7M
Total Non-Current Assets2.74B2.87B3.96B3.97B366.13M328.74M259.78M246.21M242.22M235.45M201.71M160.99M156.56M120.8M107.66M97.16M94.21M70.41M60.73M54.19M52.02M35.51M33.7M20.07M16.66M11.44M7.93M6.8M6.8M4.1M
Property, Plant & Equipment497M356.28M291.89M198.75M110.58M100.45M78.67M74.85M73.07M61.75M54.68M44.47M41.95M34.34M29.93M22.34M19.18M17.06M16.89B16.4M14.26M12.19M10.95M4.64M3.74M2.72M2.65M2.1M1.9M1.6M
Fixed Asset Turnover1.75x2.51x3.17x4.14x4.77x4.66x5.32x5.53x5.45x5.80x5.88x6.37x5.90x6.04x6.15x7.73x7.33x6.96x0.01x5.25x5.08x5.15x5.07x10.02x10.99x12.82x8.86x10.57x9.74x9.56x
Goodwill1.05B1.06B2.14B2.14B142.7M131.48M110.34M103.62M99.56M104.76M88.51M70.12M68.19M59.49M53.05M51.58M52.9M39.72M30.62M24.45M28.94M0013.66M11.21M00000
Intangible Assets1.32B1.41B1.51B1.61B107.5M92.32M66.58M67.61M69.59M68.94M58.52M46.39M46.42M28.27M24.67M17.17M17.16M9.87M9.57M9.36M2.08M20.68M19.29M007.08M3.89M3.2M4M2M
Long-Term Investments00229K0000000000000-5.75M-200M0-1.44B0-1.3B00000000
Other Non-Current Assets-120.8M35.23M20.2M7.77M-1.59M620K647K-15.48M-3.97M-6.77M-1.77M0-1.71M0-1.33M5.02M9.95M3.76M-18.09B3.97M-1.97B2.64M-870.54M-692.24M1.7M1.65M1.38M1.5M900K500K
Total Assets3.35B3.44B4.55B4.55B992.93M920.19M797.18M695.74M618.01M528.41M451.71M392.18M345.3M289.25M251.6M219.66M180.23M142.18M126.36M105.28M88.29M63.88M59.98M48.04M39.9M33.02M29.53M26.1M25.4M23.1M
Asset Turnover0.26x0.26x0.20x0.18x0.53x0.51x0.52x0.60x0.64x0.68x0.71x0.72x0.72x0.72x0.73x0.79x0.78x0.84x0.81x0.82x0.82x0.98x0.93x0.97x1.03x1.06x0.80x0.85x0.73x0.66x
Asset Growth %-2.84%-24.29%-0.12%358.69%7.9%15.43%14.58%12.58%16.96%16.98%15.18%13.58%19.38%14.96%14.54%21.88%26.77%12.52%20.02%19.25%38.2%6.52%24.85%20.38%20.84%11.83%13.13%2.76%9.96%100.87%
Total Current Liabilities158.2M174.01M154.32M145.47M77.84M53.6M48.49M38.25M38.69M36M28.6M25.46M24.97M17.72M19.98M17.8M17.03M9.25M11.14M10.04M10.02M5.74M5.66M5.76M3.96M3.33M3.34M1.9M1.4M1.8M
Accounts Payable79.1M79.61M83.06M76.67M34.61M23.9M25.65M19.06M20.75M16.24M15.8M13.69M13.4M9.21M10.76M8.52M7.19M3.91M6.5M4.51M2.83M2.35M3.06M3.27M2.33M1.21M1.74M800K600K800K
Days Payables Outstanding62.5161.3965.6867.1944.4634.4342.1931.335.7831.3134.2834.8539.1834.342.8736.6238.8424.0748.2739.5729.1826.6539.9454.8942.0925.6864.1733.9530.4252.14
Short-Term Debt019.3M2.45M3.28M01.28M000000000000000000049K499K00100K
Deferred Revenue (Current)3.6M5.56M4.63M4.62M5.46M3.4M000000000000000000000000
Other Current Liabilities75.5M44.8M26.24M25.53M11.12M0012.1M11.87M14.76M0005.12M5.65M6.57M4.66M1.48M302K2.42M4.67M1.71M000165K1.09M1.1M800K900K
Current Ratio3.82x3.32x3.82x4.03x8.05x11.03x11.08x11.75x9.71x8.14x8.74x9.08x7.56x9.51x7.20x6.88x5.05x7.76x5.89x5.09x3.62x4.95x4.65x4.85x5.87x6.47x6.47x10.16x13.29x10.56x
Quick Ratio2.91x2.22x2.59x3.11x6.48x9.16x9.12x9.50x7.75x6.11x6.49x7.06x5.51x7.34x5.45x5.09x3.21x4.37x3.40x3.19x1.86x2.54x2.46x3.15x3.67x4.38x4.86x7.84x10.07x8.56x
Cash Conversion Cycle113.08148.38152.31118.09181.67182.17188.08182.68167.83179.54182.25172.84187.06176.49167.24161.47201.67240.85227.1191.45218.51190.85186.69169.02172.23185.72210.09207.05258.87230.21
Total Non-Current Liabilities1.09B1.2B1.25B1.27B27.71M26.22M23.52M19.59M19.15M20.65M18.96M15.76M14.03M13.24M12.57M12.89M10.15M4.25M3.97M3.3M12.85M3.31M6.48M871K394K350K387K400K400K300K
Long-Term Debt0874.81M888.39M885.44M00000000000000009.96M03.9M0028K77K100K200K200K
Capital Lease Obligations012.86M10.3M8.81M0091300000000000000000000000
Deferred Tax Liabilities257.6M280.91M326.72M353.43M17.01M21.92M18.13M15.62M14.1M17.05M16.53M13.71M12.15M12.45M9.97M8.35M5.82M2.73M2.33M1.44M1.98M0874K405K000000
Other Non-Current Liabilities837.3M29.99M24.96M27.07M10.7M4.3M5.39M3.97M5.04M3.6M2.42M2.05M1.88M2.1M2.59M4.54M4.32M1.53M1.64M1.86M913K3.31M1.7M466K394K322K310K300K200K100K
Total Liabilities1.25B1.37B1.4B1.42B105.56M79.81M72M57.84M57.83M56.65M47.55M41.22M39M30.96M32.55M30.68M27.18M13.5M15.11M13.34M23.74M9.05M12.13M6.63M4.36M3.69M3.72M2.3M1.8M2.1M
Total Debt0912.61M906.24M897.53M01.29M1.05M00000000000009.96M03.9M0077K576K100K200K300K
Net Debt-185.5M783.61M735.63M734.29M-44.47M-74.32M-65.21M-41.69M-83.07M-77.57M-55.26M-66.06M-40.67M-50.03M-49.05M-35.84M-8.82M-8.5M-14.27M-2.02M8.15M-1.97M2.54M-1.06M-2.01M-771K-1.62M-1M-500K-400K
Debt / Equity-0.44x0.29x0.29x-0.00x0.00x-------------0.15x-0.08x--0.00x0.02x0.00x0.01x0.01x
Debt / EBITDA-6.76x4.56x7.13x-0.01x0.01x-------------0.75x-0.44x--0.01x0.17x0.03x0.09x0.15x
Net Debt / EBITDA-5.80x3.70x5.83x-0.54x-0.78x-0.76x-0.49x-0.95x-0.97x-0.81x-1.04x-0.77x-1.04x-1.23x-0.87x-0.28x-0.35x-0.66x-0.12x0.62x-0.19x0.28x-0.13x-0.31x-0.14x-0.49x-0.29x-0.22x-0.20x
Interest Coverage-0.38x-14.85x0.84x0.61x836.21x964.97x------------------------
Total Equity2.09B2.07B3.14B3.13B887.37M840.38M725.18M637.9M560.17M471.9M404.12M350.95M306.24M258.35M219.27M188.98M153.44M128.68M111.25M91.94M64.55M54.84M47.84M41.4M35.55M29.34M25.8M23.8M23.6M21M
Equity Growth %1.05%-34.12%0.32%253.2%5.59%15.89%13.68%13.87%18.71%16.77%15.15%14.6%18.54%17.82%16.03%23.16%19.24%15.67%20.99%42.44%17.71%14.62%15.55%16.47%21.16%13.69%8.42%0.85%12.38%135.96%
Book Value per Share9.629.5514.5216.598.217.856.866.085.374.614.003.513.082.662.281.991.661.421.241.080.750.600.530.480.500.440.390.340.330.33
Total Shareholders' Equity2.09B2.07B3.14B3.13B887.37M840.38M725.18M637.9M560.17M471.76M404.16M350.96M306.3M258.29M219.05M188.65M153.05M128.68M111.25M91.94M64.55M54.84M47.84M41.4M35.55M29.34M25.8M23.8M23.6M21M
Common Stock34.8M34.73M34.66M34.6M17.25M17.2M16.94M8.36M8.28M8.15M6.01M5.94M5.88M5.77M3.78M3.73M3.62M2.36M2.32M1.5M1.33M1.3M1.28M992K977K932K924K900K00
Retained Earnings-544.3M-536.42M555.62M565.04M587.91M539.6M478.72M419.25M359.07M295.93M252.13M215.57M182.04M153.88M126.69M104.06M81.17M63.59M49.72M37.62M34.53M26.59M20.68M15.58M10.79M6.84M3.67M600K-1.7M-3.9M
Treasury Stock000000000000000000000000000000
Accumulated OCI-13.6M-28.9M-30.02M-33.25M-27.77M-11.38M-19.71M-11.64M-9.75M-7.2M-3.95M-2.44M371K-1.37M-1.23M-394K-1.68M-430K421K386K85K136K99K3K-5.33M-4.92M-42.05M-34.2M-3.4M-3M
Minority Interest000000000143K-37K-11K-61K66K215K333K388K0000000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityWeak
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Integration and margin recovery

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q4)

Balance Sheet Shrinking Amid Integration

Total assets contracted from $4.6B in 2024Q3 to $3.3B in 2026Q4, a 28% decline, driven by goodwill write-downs and retained earnings erosion, as reported in quarterly filings.

The balance sheet has contracted significantly over the past ten quarters, with total assets falling from $4.6B to $3.3B. This decline is primarily attributable to a $1.1B reduction in goodwill, reflecting impairment charges taken during the integration of the 3M Food Safety business. The retained earnings swing from positive $561M to negative $544M underscores the magnitude of non-cash charges, which have eroded equity despite positive operating cash flow. This trajectory suggests the company is still absorbing the financial shock of the merger, and investors should monitor whether asset stabilization occurs as integration progresses.

Leverage Creeping Higher on Flat Debt

Total debt remained near $793M in 2026Q4, but equity erosion lifted the D/E ratio to 0.38 from 0.28 a year earlier, as per balance sheet data.

While absolute debt has been reduced from $912.6M in 2025Q4 to $793.3M in 2026Q4, the debt-to-equity ratio has increased from 0.28 to 0.38 over the same period due to a shrinking equity base. This indicates that the company's leverage is rising not from new borrowing but from the depletion of equity through accumulated losses. The debt level appears manageable relative to assets, but the trend warrants monitoring as continued losses could further pressure the ratio. The discrepancy between the reported D/E and the potential debt assumed in the 3M transaction remains a concern, as the current figures may not fully capture off-balance-sheet obligations.

Goodwill Impairment Masks Asset Quality

Goodwill fell from $2.1B to $1.0B over ten quarters, while PPE rose to $497M, indicating a shift toward tangible assets, as disclosed in financial statements.

The composition of assets has shifted markedly, with goodwill declining by over $1B, reflecting impairment charges that have reduced intangible asset exposure. In contrast, net PPE has increased from $287.6M to $497.0M, suggesting investment in physical capacity, possibly to support the combined operations. This shift may improve asset quality by reducing reliance on potentially overvalued intangibles, but the remaining $1.0B goodwill still represents a significant portion of total assets and could be subject to further impairment if the business underperforms. The increase in PPE indicates a more asset-heavy model, which could lead to higher depreciation and maintenance costs.

Retained Earnings Erosion Pressures Equity

Retained earnings swung from $561M positive in 2024Q3 to -$544M in 2026Q4, a $1.1B reversal, as reported in quarterly balance sheets.

The equity base has been severely impacted by the cumulative losses recorded over the past two years, with retained earnings turning deeply negative. This erosion is primarily due to non-cash charges related to the 3M acquisition, including goodwill impairments and inventory step-up costs. Despite this, total equity remains at $2.1B, supported by the initial capital raised in the merger. The negative retained earnings may restrict future dividend payments or share repurchases, and the company may need to generate sustained profitability to rebuild this buffer. Investors should monitor whether the company can return to positive retained earnings within a reasonable timeframe.

Liquidity Buffer Strengthens Despite Losses

Current ratio improved to 3.82 in 2026Q4 from 3.32 a year earlier, while cash rose to $185.5M, as per balance sheet data.

The company's liquidity position has strengthened, with the current ratio rising from 3.32 to 3.82 over the past year, indicating a robust ability to cover short-term obligations. Cash balances have increased from $129.0M to $185.5M, providing a cushion against operational volatility. This improvement is notable given the ongoing integration costs and negative GAAP profitability, suggesting that working capital management has been effective. The strong liquidity position may provide flexibility to fund integration initiatives or weather further operational disruptions, but the negative operating margin indicates that cash generation from core operations remains under pressure.

Deferred Revenue Signals Weak Visibility

Deferred revenue fell to $3.6M in 2026Q4 from $5.8M a year earlier, a 38% decline, as reported in quarterly filings.

The decline in deferred revenue, from $5.8M to $3.6M, may indicate weakening forward visibility for the company's services, particularly in the genomics segment where prepayments are common. This could suggest that customers are less willing to commit upfront, potentially reflecting uncertainty about the company's post-integration offerings. While the absolute amounts are small relative to total revenue, the trend warrants monitoring as it may signal softer demand or a shift in contract terms. Investors should assess whether this is a temporary integration effect or a more structural change in customer behavior.

NEOG — Frequently Asked Questions

Quick answers to the most common questions about buying NEOG stock.

What are the total assets of Neogen Corporation (NEOG)?

As of 2026, Neogen Corporation (NEOG) had total assets of $3.35B including $604.6M in current assets.

How much debt does Neogen Corporation (NEOG) have?

Neogen Corporation (NEOG) carries total debt of $0.0M, offset by $185.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Neogen Corporation?

Neogen Corporation (NEOG) has total shareholders' equity (book value) of $2.09B ($9.62 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Neogen Corporation's current ratio and liquidity?

Neogen Corporation (NEOG) reported a current ratio of 3.82x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.